Aggressive efforts by healthcare organizations to raise awareness are set to increase demand for breast imaging technology worldwide. These initiatives will help individuals gain information on the availability of imaging technologies that can be used to screen and diagnose breast cancer, and will drive market growth.
According to the report, the Global Breast Imaging Technologies Market accounted for $2.54 billion in 2015 and is expected to reach $4.50 billion by 2022, registering a CAGR of 8.4% during the study period.
Increasing prevalence of breast cancer, rapid technological advancements, and increase in awareness regarding breast cancer have boosted the growth of the global breast imaging technologies market. However, high cost of breast cancer detection imaging modalities and stringent regulatory approval procedure hamper the market growth. On the contrary, untapped markets in the emerging countries are expected to create lucrative opportunities in the near future.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/5056
The report includes analysis of the major market players such as FUJIFILM Holdings Corporation, Dilon Technologies, Inc., General Electric Company, Gamma Medica, Inc., Koning Corporation, Hologic, Inc., Siemens AG, Koninklijke Philips N.V., Sonocin, Inc., and Toshiba Corporation.
Global breast imaging technologies market is divided on the basis of product type and region. Based on product type, the market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing breast imaging technologies segment held the largest share in 2015, owing to its ability to identify breast imaging tools facilitate faster interpretation of breast tissues and create less false positive results as compared to MRI. However, the non-ionizing breast imaging technologies segment is expected to manifest the fastest CAGR through 2022, owing to introduction of better imaging models including automated whole breast ultrasound system (ABUS). Moreover, these techniques use infrared radiations, which have a better chance of reducing the risk of the development of radiation-induced cancer.
The ionizing breast imaging technologies segment is further divided into analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone beam computed tomography (CBCT), and positron emission mammography (PEM). The full-field digital mammography systems segment held the largest share in 2015, as it is time efficient and needless radiation dose than other technologies. Moreover, radiologists can adjust the brightness of the breast image, making it easier to observe the breast tissues. However, the 3D breast tomosynthesis segment is estimated to register the fastest CAGR during the forecast period, as this method offers easy detection of breast cancer in women with dense breast tissues.
Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. The market in North America held the largest share in 2015 and is projected to maintain its dominance throughout the forecast period, owing to increase in the prevalence of breast cancer and surge in awareness regarding cancer among patients. However, Asia-Pacific region is expected to register a CAGR of 9.5% during the forecast period.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/5056